← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksKMBAnalysis
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets
Analysis OverviewHoldUpdated May 1, 2026

KMB logoKimberly-Clark Corporation (KMB) Stock Analysis

Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.

Analyst consensus
Hold
Covering
31
analysts
10 bullish · 3 bearish · 31 covering KMB
Strong Buy
0
Buy
10
Hold
18
Sell
3
Strong Sell
0
Consensus Target
$110
+13.2% vs today
Scenario Range
$61 – $127
Model bear to bull value window
Coverage
31
Published analyst ratings
Valuation Context
12.9x
Forward P/E · Market cap $32.3B

Decision Summary

Kimberly-Clark Corporation (KMB) is rated Hold by Wall Street. 10 of 31 analysts are bullish, with a consensus target of $110 versus a current price of $97.20. That implies +13.2% upside, while the model valuation range spans $61 to $127.

Note: Strong analyst support doesn't guarantee returns. At 12.9x forward earnings, much of the optimism may already be priced in. Use the scenario range to judge whether the upside justifies the risk.
Upside case
Street consensus points to +13.2% upside. The bull scenario stretches to +30.4% if KMB re-rates higher.
Downside frame
The bear case maps to $61 — a -37.2% drop — if investor confidence compresses the multiple sharply.

KMB price targets

Three scenarios for where KMB stock could go

Current
~$97
Confidence
59 / 100
Updated
May 1, 2026
Where we are now
you are here · $97
Bear · $61
Base · $94
Bull · $127
Current · $97
Bear
$61
Base
$94
Bull
$127
Upside case

Bull case

$127+30.4%

KMB would need investors to value it at roughly 17x earnings — about 4x more generous than today's 13x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.

Market caseClosest to today

Base case

$94-3.7%

This is close to how the market is already pricing KMB — at roughly 12x forward earnings. No dramatic re-rating needed, just steady execution on the core business.

Stress case

Bear case

$61-37.2%

If investor confidence fades or macro conditions deteriorate, a 5x multiple contraction could push KMB down roughly 37% from where it trades now.

Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

KMB logo

Kimberly-Clark Corporation

KMB · NASDAQConsumer DefensiveHousehold & Personal ProductsDecember year-end
Data as of May 1, 2026

Kimberly-Clark is a global manufacturer of personal care and consumer tissue products sold under well-known brands like Huggies, Kleenex, and Scott. It generates revenue primarily through three segments: Personal Care (~50% of sales), Consumer Tissue (~35%), and K-C Professional (~15%), selling to retailers, distributors, and commercial customers. The company's competitive advantage lies in its powerful portfolio of essential household brands with strong consumer loyalty and extensive global distribution networks.

Market Cap
$32.3B
Revenue TTM
$16.5B
Net Income TTM
$2.1B
Net Margin
12.8%

KMB Revenue and Earnings Performance

Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.

EPS Beat Rate
83%Exceptional
12 quarters tracked
Revenue Beat Rate
33%Exceptional
vs consensus estimates
Avg EPS Surprise
+7.5%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026
Q2 2026

Last 4 Quarters

EPS beats: 4 of 4
Q3 2025
EPS
$1.92/$1.67
+15.0%
Revenue
$4.2B/$4.8B
-14.1%
Q4 2025
EPS
$1.82/$1.75
+4.0%
Revenue
$4.1B/$4.1B
+0.9%
Q1 2026
EPS
$1.86/$1.81
+2.8%
Revenue
$4.1B/$4.1B
-0.3%
Q2 2026
EPS
$1.97/$1.93
+2.1%
Revenue
$4.2B/$4.1B
+1.9%
QuarterEPS (Actual / Est)EPS SurpriseRevenue (Actual / Est)Rev Surprise
Q3 2025$1.92/$1.67+15.0%$4.2B/$4.8B-14.1%
Q4 2025$1.82/$1.75+4.0%$4.1B/$4.1B+0.9%
Q1 2026$1.86/$1.81+2.8%$4.1B/$4.1B-0.3%
Q2 2026$1.97/$1.93+2.1%$4.2B/$4.1B+1.9%
FY1–FY2 Estimates
Revenue Outlook
FY1
$15.6B
-5.6% YoY
FY2
$14.4B
-8.1% YoY
EPS Outlook
FY1
$6.28
-1.3% YoY
FY2
$5.85
-6.9% YoY
Trailing FCF (TTM)$2.6B
FCF Margin: 15.6%
Next Earnings
—
Expected EPS
—
Expected Revenue
—

KMB beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.

KMB Revenue Breakdown by Segment

Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.

Latest disclosure
FY 2025
Total disclosed revenue $16.3B

Product Mix

Latest annual revenue by segment or product family

Diapers
41.5%
YoY unavailable

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix

Geographic Mix

Latest annual revenue by reported region

UNITED STATES
100.0%
YoY unavailable

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix
Diapers is the largest disclosed segment at 41.5% of FY 2025 revenue, with no year-over-year comparison yet.
UNITED STATES is the largest reported region at 100.0%, with no year-over-year comparison yet.
See full revenue history

KMB Valuation Snapshot

Current multiples compared to the S&P 500, the company's sector, and its own five-year average.

Relative Value Signal
Fairly Valued

Fair value est. $98 — implies +0.1% from today's price.

Upside to Fair Value
0.1%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
KMB
16.0x
vs
S&P 500
25.1x
36% discount
vs Consumer Defensive Trailing P/E
KMB
16.0x
vs
Consumer Defensive
19.1x
16% discount
vs KMB 5Y Avg P/E
Today
16.0x
vs
5Y Average
21.5x
26% discount
Forward PE
12.9x
S&P 500
19.1x
-32%
Consumer Defensive
15.0x
-14%
5Y Avg
—
—
Trailing PE
16.0x
S&P 500
25.1x
-36%
Consumer Defensive
19.1x
-16%
5Y Avg
21.5x
-26%
PEG Ratio
—
S&P 500
1.72x
—
Consumer Defensive
1.87x
—
5Y Avg
—
—
EV/EBITDA
12.5x
S&P 500
15.2x
-18%
Consumer Defensive
11.5x
+9%
5Y Avg
14.8x
-16%
Price/FCF
19.7x
S&P 500
21.1x
-7%
Consumer Defensive
14.9x
+32%
5Y Avg
21.1x
-7%
Price/Sales
1.9x
S&P 500
3.1x
-40%
Consumer Defensive
0.8x
+127%
5Y Avg
2.2x
-14%
Dividend Yield
5.13%
S&P 500
1.87%
+174%
Consumer Defensive
2.79%
+84%
5Y Avg
3.80%
+35%
MetricKMBS&P 500· delta vs KMBConsumer Defensive5Y Avg KMB
Forward PE12.9x
19.1x-32%
15.0x-14%
—
Trailing PE16.0x
25.1x-36%
19.1x-16%
21.5x-26%
PEG Ratio—
1.72x
1.87x
—
EV/EBITDA12.5x
15.2x-18%
11.5x
14.8x-16%
Price/FCF19.7x
21.1x
14.9x+32%
21.1x
Price/Sales1.9x
3.1x-40%
0.8x+127%
2.2x-14%
Dividend Yield5.13%
1.87%
2.79%
3.80%
KMB trades above S&P 500 benchmarks on 0 of 5 measured multiples — appears modestly priced relative to the S&P 500 on most measures.

Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.

Open valuation tool

KMB Financial Health

Verdict
Exceptional

KMB generates $2.6B in free cash flow at a 15.6% margin — 23.3% ROIC signals a durable competitive advantage · returns 5.6% of market cap to shareholders annually.

Cash Engine

Revenue, margins, and cash generation

Revenue (TTM)
Trailing-twelve-month sales base
$16.5B
Revenue Growth
TTM vs prior year
-8.8%
Gross Margin
Gross profit as a share of revenue
35.9%
Operating Margin
Operating income divided by revenue
13.3%
Net Margin
Net income divided by revenue
12.8%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$6.36
Free Cash Flow (TTM)
Cash generation after capex
$2.6B
FCF Margin
FCF as share of revenue — the primary cash quality signal
15.6%

Capital Quality

ROIC, leverage, and debt serviceability

ROIC
Return on invested capital — primary competitive quality signal
23.3%
ROA
Return on assets, trailing twelve months
12.5%
Cash & Equivalents
Liquid assets on the balance sheet
$688M
Net Debt
Total debt minus cash
$6.5B
Debt Serviceability
Net debt as a multiple of annual free cash flow
2.5× FCF

~2.5 years to full repayment at current FCF run-rate

ROE *
Return on equity, trailing twelve months
131.7%

* Elevated by buyback-compressed equity — compare ROIC (23.3%) for an undistorted picture of capital efficiency.

Shareholder Returns

How capital is returned to owners

Total shareholder yield
5.6%
Dividend
5.1%
Buyback
0.4%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$141M
Dividend / Share
Annualized trailing dividend per share
$4.98
Payout Ratio
Share of earnings distributed as dividends
82.1%
Shares Outstanding
Declining as buybacks retire shares
332M

All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.

Open full ratios page

KMB Stock Risk Factors

Key factors that could pressure the stock price, compress the multiple, or weigh on future results.

AI analysis · updated April 11, 2026

01
High Risk

Raw Material Costs & Availability

Significant increases in pulp, petroleum-based materials, energy, and transportation costs can erode margins. Supplier constraints and consolidation may limit supply sources, potentially disrupting production and sales.

02
High Risk

Foreign Market Risks

International operations expose KMB to currency fluctuations, political, social, and economic instability. Changes in exchange rates or regulatory restrictions can increase costs and reduce revenue.

03
Medium

Debt & Financing

KMB’s net debt to EBITDA ratio indicates moderate debt usage, but significant liabilities remain. Interest coverage is strong, yet refinancing risk or rising rates could pressure cash flow.

04
Medium

Competitive Pressures

Intense competition may force price reductions, impacting gross margins. Market share erosion against private-label and lower-cost competitors could reduce earnings.

05
Medium

Reputational Damage

Negative publicity or product recalls could erode consumer trust in flagship brands like Huggies and Kleenex. Brand damage may lead to declining sales and higher marketing spend.

06
Lower

Climate Change Risk

Climate-related events could disrupt supply chains or increase regulatory costs. The company’s ERM program addresses these risks, but impacts remain uncertain.

These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.

Why KMB Stock Could Outperform

Structural drivers behind the upside case and why the stock could outperform over the next 12 months.

AI analysis · updated April 11, 2026

01

Undervalued with 40‑50% Upside

At current prices, KMB trades below its intrinsic value, offering a 40‑50% upside over the next one to two years as valuation normalizes. This rare entry point is supported by long‑term trend and business quality.

02

Defensive Consumer Staples Resilience

Kimberly‑Clark operates in the consumer staples sector, less sensitive to economic downturns. Products such as Huggies, Kleenex, and Depend maintain consistent demand across cycles.

03

Kenvue Acquisition Drives Growth

The acquisition of Kenvue creates a “monster” with over $32 billion in annual revenue. Expected cost synergies and margin improvement are viewed as permanent, despite initial market concerns over debt and dilution.

04

Operational Efficiency & Productivity Gains

Focused productivity and supply‑chain initiatives have delivered record gains, generating significant cost savings and margin expansion. Management plans to reinvest these efficiencies to expand the global footprint.

05

International Market Share Expansion

KMB is gaining outsized market share in high‑margin international markets, notably China for diapers and Indonesia for femcare products. The company is also recognized as a growth leader in the U.S. CPG market.

06

Strong Free Cash Flow & Dividend Growth

The firm generates roughly $1.6 billion in free cash flow annually and has increased its dividend for over 50 consecutive years, underscoring financial robustness.

A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.

Price target page

KMB Stock Price Performance

52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.

Current Price
$97.20
52W Range Position
9%
52-Week Range
Current price plotted between the 52-week low and high.
9% through range
52-Week Low
$92.42
+5.2% from the low
52-Week High
$144.31
-32.6% from the high
1 Month
+0.21%
3 Month
-6.77%
YTD
-4.1%
1 Year
-25.7%
3Y CAGR
-12.5%
5Y CAGR
-6.4%
10Y CAGR
-2.7%

Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.

Full price historyP/E history

KMB vs Peers

Valuation, growth, and margin comparison against the closest publicly traded peers for this company.

Peer Set
Accurate peer set
Forward PE
12.9x
vs 14.7x median
-12% below peer median
Revenue Growth
-5.6%
vs +0.9% median
-728% below peer median
Net Margin
12.8%
vs 11.2% median
+15% above peer median
CompanyMkt CapFwd PERev GrwMarginRatingUpside
KMB
KMB
Kimberly-Clark Corporation
$32.3B12.9x-5.6%12.8%Hold+13.2%
PG
PG
The Procter & Gamble Company
$338.6B21.0x+0.9%14.7%Buy+11.7%
CHD
CHD
Church & Dwight Co., Inc.
$22.2B24.9x+1.5%11.8%Buy+6.5%
ENR
ENR
Energizer Holdings, Inc.
$1.2B5.4x+1.2%6.5%Hold+30.0%
COT
COTY
Coty Inc.
$2.3B9.4x-0.1%-9.3%Hold+56.6%
CLX
CLX
The Clorox Company
$10.4B14.7x-0.4%11.2%Hold+22.5%

This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.

KMB Dividend and Capital Return

KMB returns 5.6% total yield, led by a 5.13% dividend, raised 27 consecutive years.

Dividend WatchFCF Adequate
Total Shareholder Yield
5.6%
Dividend + buyback return per year
Buyback Yield
0.4%
Dividend Yield
5.13%
Payout Ratio
82.1%
How KMB Splits Its Return
Div 5.13%
Dividend 5.13%Buybacks 0.4%

Dividend Profile

Yield, cadence, and growth quality

Dividend / Share
Trailing annualized cash dividend
$4.98
Growth Streak
Consecutive years of dividend increases
27Y
3Y Div CAGR
2.8%
5Y Div CAGR
3.3%
Ex-Dividend Date
—
Payment Cadence
Quarterly
4 payments over the last 12 months

Buyback Engine

How much per-share support comes from repurchases

Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$141M
Estimated Shares Retired
1M
Approx. Share Reduction
0.4%
Shares Outstanding
Current diluted share count from the screening snapshot
332M
YearDiv / ShareYoY GrwBB YieldTotal Yield
2026$1.28———
2025$5.04+3.3%0.4%5.4%
2024$4.88+3.4%2.3%6.0%
2023$4.72+1.7%0.5%4.4%
2022$4.64+1.8%0.2%3.6%
Full dividend history
FAQ

KMB Investor Questions

Common questions answered from live analyst data and company financials.

7 questions
01

Is Kimberly-Clark Corporation (KMB) stock a buy or sell in 2026?

Kimberly-Clark Corporation (KMB) is rated Hold by Wall Street analysts as of 2026. Of 31 analysts covering the stock, 10 rate it Buy or Strong Buy, 18 rate it Hold, and 3 rate it Sell or Strong Sell. The consensus 12-month price target is $110, implying +13.2% from the current price of $97. The bear case scenario is $61 and the bull case is $127.

02

What is the KMB stock price target for 2026?

The Wall Street consensus price target for KMB is $110 based on 31 analyst estimates. The high-end target is $125 (+28.6% from today), and the low-end target is $99 (+1.9%). The base case model target is $94.

03

Is Kimberly-Clark Corporation (KMB) stock overvalued in 2026?

KMB trades at 12.9x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.

04

What are the main risks for Kimberly-Clark Corporation (KMB) stock in 2026?

The primary risks for KMB in 2026 are: (1) Raw Material Costs & Availability — Significant increases in pulp, petroleum-based materials, energy, and transportation costs can erode margins. (2) Foreign Market Risks — International operations expose KMB to currency fluctuations, political, social, and economic instability. (3) Debt & Financing — KMB’s net debt to EBITDA ratio indicates moderate debt usage, but significant liabilities remain. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.

05

What is Kimberly-Clark Corporation's revenue and earnings forecast?

Analyst consensus estimates KMB will report consensus revenue of $15.6B (-5.6% year-over-year) and EPS of $6.28 (-1.3% year-over-year) for the upcoming fiscal year. The following year, analysts project $14.4B in revenue.

06

When does Kimberly-Clark Corporation (KMB) report its next earnings?

A confirmed upcoming earnings date for KMB is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.

07

How much free cash flow does Kimberly-Clark Corporation generate?

Kimberly-Clark Corporation (KMB) generated $2.6B in free cash flow over the trailing twelve months — a free cash flow margin of 15.6%. KMB returns capital to shareholders through dividends (5.1% yield) and share repurchases ($141M TTM).

Continue Your Research

Kimberly-Clark Corporation Stock Overview

Price chart, key metrics, financial statements, and peers

KMB Valuation Tool

Is KMB cheap or expensive right now?

Compare KMB vs PG

Side-by-side financials, valuation, and ratings

Deep Dive Analysis

KMB Price Target & Analyst RatingsKMB Earnings HistoryKMB Revenue HistoryKMB Price HistoryKMB P/E Ratio HistoryKMB Dividend HistoryKMB Financial Ratios

Related Analysis

The Procter & Gamble Company (PG) Stock AnalysisChurch & Dwight Co., Inc. (CHD) Stock AnalysisEnergizer Holdings, Inc. (ENR) Stock AnalysisCompare KMB vs CHDS&P 500 Mega Cap Technology Stocks
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.